APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
Advanced age is the most important and independent risk factor for the development of atrial fibrillation (AF). The proportion of patients with AF at the age of 65-85 years reaches 70%, and average age of patients with AF is 75 years. Antithrombotic therapy of AF in the elderly is challenging for se...
Saved in:
| Main Authors: | E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2017-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1457 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01) -
RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01) -
ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01) -
Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020
by: A. S. Gerasimenko, et al.
Published: (2022-01-01) -
ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY
by: E. А. Ushkalova, et al.
Published: (2017-03-01)